Scots attack Sanofi-Aventis anti-clot drug patent

25th January 2005, Comments 0 comments

PARIS, Jan 25 (AFP) - The French pharmaceutical group Sanofi-Aventis said on Tuesday that a Scottish company Aircoat was attacking Sanofi's patent for its high-earning drug Plavix in a Scottish court.

PARIS, Jan 25 (AFP) - The French pharmaceutical group Sanofi-Aventis said on Tuesday that a Scottish company Aircoat was attacking Sanofi's patent for its high-earning drug Plavix in a Scottish court.

Sanofi-Aventis said that the challenge to its British patent, based on a European patent, was "unfounded" and that it would defend its patent rights "vigorously".

Plavix, an anti-coagulation treatment used by patients at risk from thrombosis, is used by 41 million people around the world and generated sales of EUR 1.32 billion for Sanofi in 2003.

Several manufacturers of generic forms of the treatment are challenging Sanofi's patent.

In the United States Sanofi is taking legal action against an Indian company Dr Reddy and Canadian company Apotex, both makers of generic treatments, which have asked US health athorities for permission to copy the drug.

A US court has set March 4 as the date for a preliminary hearing.

© AFP

Subject: French News

0 Comments To This Article